App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
NCT ID: NCT06367257
Last Updated: 2025-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
148 participants
INTERVENTIONAL
2024-02-29
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Status of Head and Neck Cancer Patients
NCT07068711
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
NCT04611113
Re-irradiation of Recurrent Head and Neck Cancer
NCT01973179
Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck
NCT02236936
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
NCT00002555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients in the experimental arm receive the daily reminder message via app (Emento) that they should pay attention to adequate caloric intake. In addition, these patients receive 3 screening questions about their current health and nutritional status twice a week.
In case of relevant deterioration (any negative value in the screening questions is explained under study procedure), additional further questions are asked, which are specifically aimed at the side effects of the tumor therapy (mainly dysphagia, pain). The answers will be transmitted to the radiation clinic.
If a question is answered positively, this is reported to the radiotherapy clinic on the one hand and on the other hand, the patient is asked to consult the doctor in the clinic as soon as possible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
App Usage
Patients receive the daily reminder message via app (Emento) that they should pay attention to sufficient calorie intake. In addition, these patients receive 3 screening questions about their current health and nutritional status twice a week.
App Usage
Conducting patient surveys with app
Standard
Patients in the control arm receive supportive care during and after radio(chemo)therapy according to hospital standards.
Standard of Care
supportive care during and after radio(chemo)therapy according to hospial standards
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
App Usage
Conducting patient surveys with app
Standard of Care
supportive care during and after radio(chemo)therapy according to hospial standards
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have a smartphone on which the Emento app can be installed
* Minimum age 18 years
Exclusion Criteria
* Patients who are not suitable for participation in the study due to a language barrier
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Erlangen-Nürnberg Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlen Haderlein, PD
Role: STUDY_DIRECTOR
Universitätsklinikum Erlangen, Radiation Oncology
Luitpold Distel, Prof.
Role: STUDY_DIRECTOR
Universitätsklinikum Erlangen, Radiation Oncology
Allison Lamrani
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Erlangen, Radiation Oncology
Charlotte Schmitter, Dr.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Erlangen, Radiation Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Erlangen, Strahlenklinik
Erlangen, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Emento App
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.